Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.65 |
| ▸ | RRM1 | P23921 | 1/20 | 0.63 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.59 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.59 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.59 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.54 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.47 |
| ▸ | TLR2 | O60603 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20169781 | 0.90 | GNAI3 (0.65) | DPP7RRM1GNAI3GNAO1GNAI1 | |
| SCHEMBL20169779 | 0.90 | GNAI3 (0.65) | DPP7RRM1GNAI3GNAO1GNAI1 | |
| SCHEMBL20169776 | 0.90 | GNAI3 (0.65) | DPP7RRM1GNAI3GNAO1GNAI1 | |
| SCHEMBL21467378 | 0.87 | DPP7 (0.65) | DPP7RRM1GNAI3GNAO1GNAI1 | |
| SCHEMBL14001785 | 0.86 | GNAI3 (0.65) | DPP7RRM1GNAI3GNAO1GNAI1 | |
| SCHEMBL14627818 | 0.86 | DPP7 (0.56) | DPP7RRM1GNAI3GNAO1GNAI1 | |
| SCHEMBL24072535 | 0.85 | DPP7 (0.58) | DPP7RRM1GNAI3GNAO1GNAI1 | |
| SCHEMBL14874696 | 0.85 | GNAI3 (0.58) | DPP7RRM1GNAI3GNAO1GNAI1 | |
| SCHEMBL14138765 | 0.85 | DPP7 (0.58) | DPP7RRM1GNAI3GNAO1GNAI1 | |
| SCHEMBL23430583 | 0.85 | DPP7 (0.58) | DPP7RRM1GNAI3GNAO1GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11813358-B2 | Lipid nanodisc formation by polymers having a pendant hydrophobic group | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2023-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11813358-B2 | Lipid nanodisc formation by polymers having a pendant hydrophobic group | PLIN3, ABHD16A, HDLBP | DPP7 3442/4885RRM1 1046/4885GNAI3 1559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.